Latest News
1209, 2016
-
CIC bioGUNE, CRB Inverbío, Kereon Partners and private investors create Atlas Molecular Pharma to discover new drugs for the treatment of Rare and Ultra-Rare diseases GalleryCIC bioGUNE, CRB Inverbío, Kereon Partners and private investors create Atlas Molecular Pharma to discover new drugs for the treatment of Rare and Ultra-Rare diseases
CIC bioGUNE, CRB Inverbío, Kereon Partners and private investors create Atlas Molecular Pharma to discover new drugs for the treatment of Rare and Ultra-Rare diseases
The new company, Atlas Molecular Pharma, will further develop its proprietary technology to act as a “drug discovery engine” for the discovery and development of drugs called pharmacological chaperones, which act by restoring defective protein [...]